Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward.
Get the Details Now.

MGNX Insider Trading (MacroGenics)

Insider Ownership Percentage: 7.90%
Insider Buying (Last 12 Months): $17,310,250.00
Insider Selling (Last 12 Months): $125,050.00

MacroGenics Insider Trading History Chart

This chart shows the insider buying and selling history at MacroGenics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

MacroGenics Share Price & Price History

Current Price: $4.16
Price Change: Price Decrease of -0.03 (-0.72%)
As of 05/13/2022 07:55 PM ET

This chart shows the closing price history over time for MGNX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Crypto Millionaire: “Pay Attention to May 20th”
Charlie Shrem is like the “Godfather of Cryptocurrencies”. He discovered Bitcoin when it was trading for $5. Ethereum at $109. Binance at just $6. Cardano for 5 CENTS.

Today, he’s sharing the details of a $0.21 CENT crypto with Top 5 Potential… as well as his BIG prediction for May 20th.
Get the details NOW.

MacroGenics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/19/2021Target N V BiotechMajor ShareholderBuy200,000$18.50$3,700,000.00View SEC Filing Icon  
9/28/2021Target N V BiotechMajor ShareholderBuy100,000$20.64$2,064,000.00View SEC Filing Icon  
9/16/2021Target N V BiotechMajor ShareholderBuy400,000$20.94$8,376,000.00View SEC Filing Icon  
7/16/2021Thomas SpitznagelSVPSell5,000$25.01$125,050.005,000View SEC Filing Icon  
6/21/2021Target N. V. BiotechMajor ShareholderBuy75,000$21.74$1,630,500.006,275,564View SEC Filing Icon  
6/15/2021Target N V BiotechMajor ShareholderBuy75,000$20.53$1,539,750.006,100,564View SEC Filing Icon  
4/15/2021Thomas SpitznagelSVPSell5,000$30.91$154,550.005,000View SEC Filing Icon  
3/22/2021Ezio BonviniSVPSell3,917$32.00$125,344.0079,890View SEC Filing Icon  
3/22/2021James KarrelsCFOSell15,000$33.00$495,000.00View SEC Filing Icon  
3/8/2021Jeffrey Stuart PetersGeneral CounselSell21,749$26.50$576,348.5021,749View SEC Filing Icon  
11/30/2020Eric Blasius RisserSVPSell500$23.35$11,675.0044,968View SEC Filing Icon  
10/28/2020Eric Blasius RisserSVPSell1,500$20.69$31,035.0045,968View SEC Filing Icon  
9/28/2020Eric Blasius RisserSVPSell500$25.33$12,665.0044,968View SEC Filing Icon  
9/18/2020Ezio BonviniSVPSell62,851$30.50$1,916,955.50102,146View SEC Filing Icon  
9/9/2020Kenneth GalbraithDirectorSell20,773$27.11$563,156.0313,849View SEC Filing Icon  
8/20/2020Thomas SpitznagelSVPSell7,500$26.87$201,525.00
7/27/2020Eric Blasius RisserSVPSell4,489$25.47$114,334.8344,957View SEC Filing Icon  
7/2/2020Eric Blasius RisserSVPSell3,100$30.00$93,000.00
6/24/2020Eric Blasius RisserSVPSell500$28.49$14,245.0044,968View SEC Filing Icon  
5/20/2020Thomas SpitznagelSVPSell7,500$25.30$189,750.007,500View SEC Filing Icon  
5/6/2020Eric Blasius RisserSVPSell8,032$20.95$168,270.4044,968View SEC Filing Icon  
2/20/2020Eric Blasius RisserSVPSell500$10.84$5,420.0032,968View SEC Filing Icon  
2/5/2020Eric Blasius RisserSVPSell623$10.00$6,230.0032,498View SEC Filing Icon  
5/22/2019Eric Blasius RisserSVPSell4,000$18.54$74,160.0033,806View SEC Filing Icon  
5/20/2019Eric Blasius RisserSVPSell3,000$18.38$55,140.0033,806View SEC Filing Icon  
See Full Table
Crypto Millionaire: “Pay Attention to May 20th”
Charlie Shrem is like the “Godfather of Cryptocurrencies”. He discovered Bitcoin when it was trading for $5. Ethereum at $109. Binance at just $6. Cardano for 5 CENTS.

Today, he’s sharing the details of a $0.21 CENT crypto with Top 5 Potential… as well as his BIG prediction for May 20th.
Get the details NOW.

SEC Filings (Institutional Ownership Changes) for MacroGenics (NASDAQ:MGNX)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MGNX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

MacroGenics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/13/2022Rhenman & Partners Asset Management AB287,081$2.53M0.2%-4.5%0.468%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC585,712$5.16M0.0%N/A0.955%Search for SEC Filing on Google Icon
5/13/2022Bellevue Group AG7,325,514$64.54M0.7%-14.4%11.944%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp592,510$5.22M0.0%-4.8%0.966%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.470,970$4.15M0.0%+3.2%0.768%Search for SEC Filing on Google Icon
5/13/2022Wasatch Advisors Inc.4,041,339$35.60M0.2%-1.6%6.589%Search for SEC Filing on Google Icon
5/13/2022Federated Hermes Inc.290,458$2.56M0.0%N/A0.474%Search for SEC Filing on Google Icon
5/13/2022Candriam Luxembourg S.C.A.517,592$4.56M0.0%-5.5%0.844%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.4,032,239$35.52M0.0%+2.2%6.575%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP1,160,352$10.22M0.0%-6.1%1.892%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.5,166,900$45.52M0.0%-0.5%8.424%Search for SEC Filing on Google Icon
5/12/2022Panagora Asset Management Inc.244,224$2.15M0.0%+49.3%0.398%Search for SEC Filing on Google Icon
5/12/2022Metropolitan Life Insurance Co NY3,875$34K0.0%-76.0%0.006%Search for SEC Filing on Google Icon
5/12/2022MetLife Investment Management LLC33,326$0.29M0.0%+58.3%0.054%Search for SEC Filing on Google Icon
5/12/2022CI Investments Inc.31,681$0.28M0.0%N/A0.052%Search for SEC Filing on Google Icon
5/12/2022Acadian Asset Management LLC37,468$0.33M0.0%N/A0.061%Search for SEC Filing on Google Icon
5/12/2022E Fund Management Co. Ltd.10,417$92K0.0%N/A0.017%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.36,086$0.32M0.0%-75.1%0.059%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.45,453$0.40M0.0%+14.2%0.074%Search for SEC Filing on Google Icon
5/11/2022Massachusetts Financial Services Co. MA96,898$0.85M0.0%+23.8%0.158%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.283,760$2.50M0.0%+195.5%0.463%Search for SEC Filing on Google Icon
5/10/2022ProShare Advisors LLC17,604$0.16M0.0%-18.9%0.029%Search for SEC Filing on Google Icon
5/9/2022Campbell & CO Investment Adviser LLC29,955$0.26M0.1%N/A0.049%Search for SEC Filing on Google Icon
5/9/2022Principal Financial Group Inc.269,274$2.37M0.0%+3.9%0.439%Search for SEC Filing on Google Icon
5/9/2022Swiss National Bank115,800$1.02M0.0%+7.6%0.189%Search for SEC Filing on Google Icon
5/9/2022Teacher Retirement System of Texas10,080$89K0.0%N/A0.016%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd55,550$0.49M0.0%+86.6%0.091%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund42,559$0.38M0.0%-31.0%0.069%Search for SEC Filing on Google Icon
5/5/2022Pinnacle Associates Ltd.403,616$3.56M0.1%-3.5%0.658%Search for SEC Filing on Google Icon
5/2/2022XML Financial LLC19,152$0.17M0.0%+22.2%0.031%Search for SEC Filing on Google Icon
4/28/2022DekaBank Deutsche Girozentrale18,300$0.16M0.0%+10.2%0.030%Search for SEC Filing on Google Icon
4/25/2022Assenagon Asset Management S.A.1,253,659$11.05M0.0%+618.9%2.044%Search for SEC Filing on Google Icon
4/21/2022Strs Ohio39,300$0.35M0.0%+9.2%0.064%Search for SEC Filing on Google Icon
2/23/2022Barclays PLC75,716$1.22M0.0%+13.0%0.124%Search for SEC Filing on Google Icon
2/23/2022BlackRock Inc.5,194,833$83.38M0.0%-3.1%8.480%Search for SEC Filing on Google Icon
2/19/2022Vident Investment Advisory LLC57,753$0.93M0.0%-13.2%0.094%Search for SEC Filing on Google Icon
2/19/2022Wells Fargo & Company MN57,159$0.92M0.0%-34.8%0.093%Search for SEC Filing on Google Icon
2/19/2022Woodline Partners LP269,272$4.32M0.1%-67.4%0.440%Search for SEC Filing on Google Icon
2/17/2022Goldman Sachs Group Inc.403,814$6.48M0.0%+29.8%0.659%Search for SEC Filing on Google Icon
2/16/2022Allianz Asset Management GmbH29,302$0.47M0.0%-76.9%0.048%Search for SEC Filing on Google Icon
2/16/2022Deutsche Bank AG41,246$0.66M0.0%+4.6%0.067%Search for SEC Filing on Google Icon
2/16/2022California State Teachers Retirement System74,252$1.19M0.0%+3.6%0.121%Search for SEC Filing on Google Icon
2/16/2022Parametric Portfolio Associates LLC38,552$0.62M0.0%-53.0%0.063%Search for SEC Filing on Google Icon
2/16/2022Wasatch Advisors Inc.4,108,701$65.95M0.3%-4.9%6.707%Search for SEC Filing on Google Icon
2/15/2022Stifel Financial Corp34,845$0.56M0.0%-10.3%0.057%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC1,029,536$16.52M0.0%+101.1%1.681%Search for SEC Filing on Google Icon
2/15/2022Cubist Systematic Strategies LLC40,851$0.66M0.0%-15.0%0.067%Search for SEC Filing on Google Icon
2/14/2022D. E. Shaw & Co. Inc.59,395$0.95M0.0%-24.5%0.097%Search for SEC Filing on Google Icon
2/14/2022Squarepoint Ops LLC32,586$0.52M0.0%N/A0.053%Search for SEC Filing on Google Icon
2/14/2022Perceptive Advisors LLC1,665,243$26.73M0.4%-22.5%2.718%Search for SEC Filing on Google Icon
2/14/2022Point72 Hong Kong Ltd5,361$86K0.0%+101.9%0.009%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.1,260,161$20.23M0.1%+42.6%2.057%Search for SEC Filing on Google Icon
2/14/2022Alliancebernstein L.P.82,600$1.33M0.0%-1.9%0.135%Search for SEC Filing on Google Icon
2/14/2022Credit Suisse AG48,872$0.78M0.0%-5.6%0.080%Search for SEC Filing on Google Icon
2/14/2022State Street Corp2,912,670$46.75M0.0%-1.0%4.755%Search for SEC Filing on Google Icon
2/14/2022Goldman Sachs Group Inc.403,814$6.48M0.0%+29.8%0.659%Search for SEC Filing on Google Icon
2/14/2022Nuveen Asset Management LLC342,485$5.50M0.0%-2.6%0.559%Search for SEC Filing on Google Icon
2/14/2022Barclays PLC75,716$1.22M0.0%+13.0%0.124%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP22,897$0.37M0.0%N/A0.037%Search for SEC Filing on Google Icon
2/14/2022Ally Bridge Group NY LLC30,000$0.48M0.2%-91.8%0.049%Search for SEC Filing on Google Icon
2/14/2022Invesco Ltd.40,634$0.65M0.0%-6.6%0.066%Search for SEC Filing on Google Icon
2/11/2022Geode Capital Management LLC1,018,761$16.35M0.0%-2.2%1.663%Search for SEC Filing on Google Icon
2/11/2022Charles Schwab Investment Management Inc.456,194$7.32M0.0%+1.4%0.745%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc12,980$0.21M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/11/2022Allianz Asset Management GmbH29,302$0.47M0.0%-76.9%0.048%Search for SEC Filing on Google Icon
2/10/2022Candriam Luxembourg S.C.A.547,729$8.79M0.1%-10.0%0.894%Search for SEC Filing on Google Icon
2/10/2022JPMorgan Chase & Co.96,036$1.54M0.0%-4.7%0.157%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd29,762$0.48M0.0%+47.5%0.049%Search for SEC Filing on Google Icon
2/10/2022Rafferty Asset Management LLC171,779$2.76M0.0%+65.3%0.280%Search for SEC Filing on Google Icon
2/10/2022Citigroup Inc.144,750$2.32M0.0%+2.6%0.236%Search for SEC Filing on Google Icon
2/10/2022Panagora Asset Management Inc.163,620$2.63M0.0%+54.3%0.267%Search for SEC Filing on Google Icon
2/10/2022Massachusetts Financial Services Co. MA78,299$1.26M0.0%+103.9%0.128%Search for SEC Filing on Google Icon
2/10/2022Bellevue Group AG8,560,462$137.40M1.4%+0.2%13.974%Search for SEC Filing on Google Icon
2/10/2022Connor Clark & Lunn Investment Management Ltd.39,796$0.64M0.0%+9.7%0.065%Search for SEC Filing on Google Icon
2/9/2022Principal Financial Group Inc.259,279$4.16M0.0%+1.0%0.423%Search for SEC Filing on Google Icon
2/9/2022BNP Paribas Arbitrage SA79,100$1.27M0.0%+641.0%0.129%Search for SEC Filing on Google Icon
2/9/2022AlphaCrest Capital Management LLC28,386$0.46M0.0%-23.9%0.046%Search for SEC Filing on Google Icon
2/9/2022Alps Advisors Inc.70,889$1.14M0.0%-5.4%0.116%Search for SEC Filing on Google Icon
2/9/2022Dimensional Fund Advisors LP1,235,876$19.84M0.0%+1.5%2.017%Search for SEC Filing on Google Icon
2/9/2022Fox Run Management L.L.C.11,791$0.19M0.1%N/A0.019%Search for SEC Filing on Google Icon
2/8/2022Bank of America Corp DE118,433$1.90M0.0%+222.0%0.193%Search for SEC Filing on Google Icon
2/8/2022Swiss National Bank107,600$1.73M0.0%+1.4%0.176%Search for SEC Filing on Google Icon
2/8/2022Handelsbanken Fonder AB16,400$0.26M0.0%+30.2%0.027%Search for SEC Filing on Google Icon
2/8/2022First Trust Advisors LP23,991$0.39M0.0%+25.4%0.039%Search for SEC Filing on Google Icon
2/8/2022ProShare Advisors LLC21,718$0.35M0.0%+4.7%0.035%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp622,552$9.99M0.0%-2.0%1.016%Search for SEC Filing on Google Icon
2/7/2022SG Americas Securities LLC16,799$0.27M0.0%-46.8%0.027%Search for SEC Filing on Google Icon
2/3/2022Nisa Investment Advisors LLC6,079$75K0.0%+46.5%0.010%Search for SEC Filing on Google Icon
2/2/2022Integral Health Asset Management LLC130,000$2.09M0.6%-18.8%0.212%Search for SEC Filing on Google Icon
2/2/2022Pinnacle Associates Ltd.418,391$6.72M0.1%+0.4%0.683%Search for SEC Filing on Google Icon
2/1/2022XML Financial LLC15,672$0.25M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/1/2022Assenagon Asset Management S.A.174,386$2.80M0.0%+640.9%0.285%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd29,762$0.48M0.0%+47.5%0.049%Search for SEC Filing on Google Icon
1/31/2022Dupont Capital Management Corp8,697$0.14M0.0%-28.5%0.014%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC26,318$0.42M0.0%N/A0.043%Search for SEC Filing on Google Icon
1/24/2022Strs Ohio36,000$0.58M0.0%+127.8%0.059%Search for SEC Filing on Google Icon
12/14/2021UBS Asset Management Americas Inc.48,913$1.02M0.0%-7.1%0.080%Search for SEC Filing on Google Icon
11/18/2021Bank of New York Mellon Corp197,106$4.13M0.0%+12.6%0.322%Search for SEC Filing on Google Icon
11/16/2021BNP Paribas Arbitrage SA10,675$0.22M0.0%+390.6%0.017%Search for SEC Filing on Google Icon
11/16/2021Opaleye Management Inc.462,000$9.67M1.8%-20.1%0.754%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
MacroGenics logo
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 × CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. It also develops Lorigerlimab, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3; Retifanlimab, an investigational monoclonal antibody targeting metastatic squamous cell carcinoma of the anal canal and metastatic non-small cell lung cancer; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company develops MGD014 and MGD020, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and CD3 on T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. It has collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; and Janssen Biotech, Inc. The company was incorporated in 2000 and is headquartered in Rockville, Maryland.
Read More on MacroGenics

Today's Range

Now: $4.16
Low: $4.09
High: $4.29

50 Day Range

MA: $7.95
Low: $4.10
High: $9.99

52 Week Range

Now: $4.16
Low: $3.96
High: $32.81

Volume

846,000 shs

Average Volume

664,849 shs

Market Capitalization

$255.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.13

Who are the company insiders with the largest holdings of MacroGenics?

MacroGenics' top insider shareholders include:
  1. Target N V Biotech (Major Shareholder)
  2. Target N V Biotech (Major Shareholder)
  3. Ezio Bonvini (SVP)
  4. Eric Blasius Risser (SVP)
  5. Jeffrey Stuart Peters (General Counsel)
  6. Kenneth Galbraith (Director)
  7. Thomas Spitznagel (SVP)
  8. James Karrels (CFO)
Learn More about top insider investors at MacroGenics.

Who are the major institutional investors of MacroGenics?

MacroGenics' top institutional investors include:
  1. Bellevue Group AG — 11.94%
  2. BlackRock Inc. — 8.42%
  3. Wasatch Advisors Inc. — 6.59%
  4. Vanguard Group Inc. — 6.57%
  5. Assenagon Asset Management S.A. — 2.04%
  6. Dimensional Fund Advisors LP — 1.89%
Learn More about top institutional investors of MacroGenics stock.

Which major investors are selling MacroGenics stock?

During the last quarter, MGNX stock was sold by these institutional investors:
  1. Bellevue Group AG
  2. Citigroup Inc.
  3. Dimensional Fund Advisors LP
  4. Wasatch Advisors Inc.
  5. Candriam Luxembourg S.C.A.
  6. Northern Trust Corp
  7. BlackRock Inc.
  8. New York State Common Retirement Fund

Which major investors are buying MacroGenics stock?

During the previous quarter, MGNX stock was purchased by institutional investors including:
  1. Assenagon Asset Management S.A.
  2. Renaissance Technologies LLC
  3. Federated Hermes Inc.
  4. JPMorgan Chase & Co.
  5. Vanguard Group Inc.
  6. Panagora Asset Management Inc.
  7. Acadian Asset Management LLC
  8. CI Investments Inc.
During the previous year, these company insiders have bought MacroGenics stock:
  1. Target N V Biotech (Major Shareholder)
  2. Target N V Biotech (Major Shareholder)
Learn More investors buying MacroGenics stock.
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward.
Get the Details Now.